Yadin Rozov is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 155,320 shares of ORMP, which is worth approximately $369,661. The most recent transaction as insider was on Jan 04, 2024, when has been sold 38,820 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 155K
0% 3M change
33.32% 12M change
Total Value Held $369,661

Yadin Rozov Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2024
BUY
Grant, award, or other acquisition
-
38,820 Added 20.0%
155,320 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 20.48%
116,500 Common Stock
Mar 14 2023
BUY
Open market or private purchase
$102,499 $2.05 p/Share
50,000 Added 36.63%
86,500 Common Stock
Mar 13 2023
BUY
Open market or private purchase
$39,200 $1.96 p/Share
20,000 Added 35.4%
36,500 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 42.11%
16,500 Common Stock
May 02 2022
BUY
Grant, award, or other acquisition
-
4,500 Added 50.0%
4,500 Common Stock

Also insider at

MDWT
MIDWEST HOLDING INC. Financial Services
DAVE
Dave Inc. Technology
CORZ
Core Scientific, Inc. Technology
YR

Yadin Rozov

Director
New York, NY

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP